Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway

European Journal of Clinical Pharmacology

Volumn 67, Issue 2, 2011, Pages 193-201

  Håkonsen, Helle ^a   Toverud, Else Lydia ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Adherence; Compliance; Cost containment; Generic drugs; Generic substitution; Pakistani immigrants

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GENERIC DRUG; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; DRUG COST; DRUG INFORMATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; FEMALE; HUMAN; IMMIGRANT; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; NORWAY; PAKISTAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; THERAPEUTIC MISCONCEPTION;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; DRUG SUBSTITUTION; DRUG UTILIZATION; DRUGS, GENERIC; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORWAY; PAKISTAN; POLYPHARMACY; QUESTIONNAIRES;

EID: 79151478203     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0960-9     Document Type: Article

References (29)

1. L Garattini F Tediosi 2000 A comparative analysis of generics markets in five European countries Health Policy 51 149 162 1:STN:280: DC%2BD3M%2FgsF2rtA%3D%3D 10.1016/S0168-8510(00)00061-0 10720685
2. JS Haas KA Phillips EP Gerstenberger AC Seger 2005 Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000 Ann Intern Med 142 891 897 15941695
3. H Håkonsen AM Horn EL Toverud 2009 Price control as a strategy for pharmaceutical cost containment-what has been achieved in Norway in the period 1994-2004? Health Policy 90 277 285 10.1016/j.healthpol.2008.09.018 19042052
4. P Kanavos E Mossialos 1999 Outstanding regulatory aspects in the European pharmaceutical market Pharmacoeconomics 15 519 533 1:STN:280: DyaK1MzjtFersQ%3D%3D 10.2165/00019053-199915060-00001 10538326
5. S Simoens 2008 Trends in generic prescribing and dispensing in Europe Expert Rev Clin Pharmacol 1 497 503 10.1586/17512433.1.4.497
6. P McManus DJ Birkett J Dudley A Stevens 2001 Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefits scheme in Australia Pharmacoepidemiol Drug Saf 10 295 300 1:STN:280:DC%2BD38%2FjsVeksg%3D%3D 10.1002/pds.603 11760489
7. S Mendis K Fukino A Cameron R Laing A Jr Filipe O Khatib J Leowski M Ewen 2007 The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries Bull World Health Organ 85 279 288 10.2471/BLT.06.033647 17546309
8. World Health Organization (2004) The world medicines situation. WHO, Genova, WHO/EDM/PAR/2004.5
9. Statistics Norway. Population statistics. Immigrants and Norwegian-born to immigrant parents. 1 January 2009. A half million immigrants and Norwegian-born to immigrant parents. http://www.ssb.no/emner/02/01/10/innvbef/. Accessed 10 November 2010 [in Norwegian]
10. The Norwegian Association of Pharmaceutical Manufacturers (2010). Facts and figures 2010. http://www.lmi.no/dm-documents/facts-and-figures-2010- powerpoint-ds5ok.ppt. Accessed 10 November 2010
11. ZU Babar S Jamshed 2008 Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan? Pharm World Sci 30 617 619 10.1007/s11096-008-9246-z 18686010
12. S Madsen B Nitteberg-Sørensen C Harviken H Samdal PO Roksvaag 2008 The generic list-a drug-political tool Tidsskr Nor Legeforen 128 837 839 [in Norwegian]
13. LA Reppe H Stenberg-Nilsen P Harg AB Hegge AK Lillefloth I Buajordet 2008 Adverse events related to substitution of generic products in Norway 2005 Tidsskr Nor Laegeforen 128 2696 2700 19079413 [in Norwegian]
14. S Jamshed MAA Hassali MIM Ibrahim ZU Babar 2009 Knowledge, attitude and perception of consumers towards generic medicines in Karachi, Pakistan. Abstract PESP-11 (000048) Malaysian J Pharm 1 14
15. Kiani A, Qadeer A, Mirza Z, Khanum A, Tisocki K, Mustafa T (2006) Prices, availability and affordability of medicines in Pakistan. Report of the network for consumer protection, Islamabad http://www.haiweb.org/medicineprices/surveys/ 200407PK/survey-report.pdf. Accessed 10 November 2010
16. Business Monitor International (2009) Pakistan pharmaceuticals & healthcare report Q1 2010. BMI's Industry Survey & Forecasts Series, Business Monitor International, London
17. T Kelesidis I Kelesidis PI Rafailidis ME Falagas 2007 Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence J Antimicrob Chemother 60 214 236 1:CAS:528:DC%2BD2sXos12mtrg%3D 10.1093/jac/dkm109 17550892
18. H Håkonsen M Eilertsen H Borge EL Toverud 2009 Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 25 2515 2521 10.1185/03007990903192223 19708764
19. I Kjønniksen M Lindbæk AG Granås 2006 Patients' attitudes towards and experiences of generic drug substitution in Norway Pharm World Sci 28 284 289 10.1007/s11096-006-9043-5
20. EL Toverud AK Røise G Hogstad I Wabø 2010 Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences Eur J Clin Pharmacol 10.1007/s00228-010-0935-x
21. H Håkonsen HS Hopen L Abelsen B Ek EL Toverud 2010 Generic substitution: a potential risk factor for medication errors in hospitals Adv Ther 27 118 126 10.1007/s12325-010-0007-8 20237878
22. MAA Hassali AA Shafie S Jamshed MIM Ibrahim A Awaisu 2009 Consumers' views on generic medicines: a review of the literature Int J Pharm Pract 17 79 88 20214255
23. W Himmel A Simmenroth-Nayda W Niebling T Ledig RD Jansen MM Kochen CH Gleiter E Hummers-Pradier 2005 What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 43 472 479 1:STN:280:DC%2BD2Mrmtl2lug%3D%3D 16240704
24. World Health Organization (2003) Adherence to long-term therapies: evidence for action. WHO, Genova, ISBN 9241545992
25. G Botten OG Aasland 2000 The public's expectations of the health services Tidsskr Nor Laegeforen 120 2995 2999 1:STN:280:DC%2BD3M%2FnsFemuw%3D%3D 11109384 [in Norwegian]
26. BL van Wijk OH Klungel ER Heerdink A de Boer 2006 Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother 40 15 20 16303985
27. RL Waber B Shiv Z Carmon D Ariely 2008 Commercial features of placebo and therapeutic efficacy JAMA 299 1016 1017 1:CAS:528:DC%2BD1cXjtVSlsbs%3D 10.1001/jama.299.9.1016 18319411
28. WH Shrank SM Cadarette E Cox MA Fischer J Mehta AM Brookhart J Avorn NK Choudhry 2009 Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care 47 319 325 10.1097/MLR.0b013e31818af850 19194329
29. JA Vallès M Barreiro G Cereza JJ Ferro MJ Martínez JM Escribà B Iglesias E Cucurull E Barceló 2003 A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice Health Policy 65 269 275 10.1016/S0168-8510(03) 00018-6 12941494